Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Axonics Modulation Technologies stock | $45.8

Own Axonics Modulation Technologies stock in just a few minutes.

Fact checked

Axonics Modulation Technologies, Inc is a medical devices business based in the US. Axonics Modulation Technologies shares (AXNX) are listed on the NASDAQ and all prices are listed in US Dollars. Axonics Modulation Technologies employs 302 staff and has a trailing 12-month revenue of around USD$86.7 million.

How to buy shares in Axonics Modulation Technologies

  1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
  2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
  3. Search for Axonics Modulation Technologies. Find the stock by name or ticker symbol: AXNX. Research its history to confirm it's a solid investment against your financial goals.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Axonics Modulation Technologies reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. At last close price of USD$45.8, weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of Axonics Modulation Technologies, depending on your broker.
  6. Check in on your investment. Congratulations, you own a part of Axonics Modulation Technologies. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

Axonics Modulation Technologies share price

Use our graph to track the performance of AXNX stocks over time.

Axonics Modulation Technologies shares at a glance

Information last updated 2020-12-27.
Latest market closeUSD$45.8
52-week rangeUSD$15.25 - USD$52.1
50-day moving average USD$45.3785
200-day moving average USD$43.4188
Wall St. target priceUSD$61
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) USD$-2.529

Buy Axonics Modulation Technologies shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee
Sofi Invest
$0
Stocks, ETFs, Cryptocurrency
N/A
0%
A free way to invest in stocks, ETFs and crypto.
Robinhood
$0
Stocks, Options, ETFs, Cryptocurrency
$0
0%
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Moomoo
$0 for US stocks
Stocks, Options, ETFs
$0
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.
TD Ameritrade
$0
or $25 broker-assisted
Stocks
$0 + $0.65/contract,
or $25 broker-assisted
TD Ameritrade features $0 commission for online stock, but watch out for high short-term ETF and broker-assisted trading fees.
loading

Compare up to 4 providers

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Axonics Modulation Technologies stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Axonics Modulation Technologies price performance over time

Historical closes compared with the close of $45.8 from 2020-12-09

1 week (2021-01-07) -12.75%
1 month (2020-12-17) 3.71%
3 months (2020-10-15) -4.60%
6 months (2020-07-15) 14.99%
1 year (2020-01-15) 50.46%
2 years (2019-01-15) 205.54%
3 years (2018-01-13) N/A
5 years (2016-01-13) N/A

Axonics Modulation Technologies financials

Revenue TTM USD$86.7 million
Gross profit TTM USD$7.3 million
Return on assets TTM -17.3%
Return on equity TTM -34.35%
Profit margin -76.49%
Book value $7.393
Market capitalisation USD$1.9 billion

TTM: trailing 12 months

Shorting Axonics Modulation Technologies shares

There are currently 5.4 million Axonics Modulation Technologies shares held short by investors – that's known as Axonics Modulation Technologies's "short interest". This figure is 4.4% up from 5.2 million last month.

There are a few different ways that this level of interest in shorting Axonics Modulation Technologies shares can be evaluated.

Axonics Modulation Technologies's "short interest ratio" (SIR)

Axonics Modulation Technologies's "short interest ratio" (SIR) is the quantity of Axonics Modulation Technologies shares currently shorted divided by the average quantity of Axonics Modulation Technologies shares traded daily (recently around 428689.21259843). Axonics Modulation Technologies's SIR currently stands at 12.7. In other words for every 100,000 Axonics Modulation Technologies shares traded daily on the market, roughly 12700 shares are currently held short.

However Axonics Modulation Technologies's short interest can also be evaluated against the total number of Axonics Modulation Technologies shares, or, against the total number of tradable Axonics Modulation Technologies shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Axonics Modulation Technologies's short interest could be expressed as 0.15% of the outstanding shares (for every 100,000 Axonics Modulation Technologies shares in existence, roughly 150 shares are currently held short) or 0.1838% of the tradable shares (for every 100,000 tradable Axonics Modulation Technologies shares, roughly 184 shares are currently held short).

A SIR above 10% would generally be considered pretty high, pointing to a potentially pessimistic outlook for the share price and a discouraging interest in betting against Axonics Modulation Technologies.

Find out more about how you can short Axonics Modulation Technologies stock.

Axonics Modulation Technologies share dividends

We're not expecting Axonics Modulation Technologies to pay a dividend over the next 12 months.

Axonics Modulation Technologies share price volatility

Over the last 12 months, Axonics Modulation Technologies's shares have ranged in value from as little as $15.25 up to $52.1. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Axonics Modulation Technologies's is -0.0014. This would suggest that Axonics Modulation Technologies's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, Axonics Modulation Technologies has bucked the trend.

Axonics Modulation Technologies overview

Axonics Modulation Technologies, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems in the United States and internationally. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence, and non-obstructive urinary retention. Its proprietary rechargeable SNM System (r-SNM) delivers mild electrical pulses to the targeted sacral nerve to restore normal communication to and from the brain to reduce the symptoms of bladder and bowel dysfunction. The company was formerly known as American Restorative Medicine, Inc. and changed its name to Axonics Modulation Technologies, Inc. in August 2013. Axonics Modulation Technologies, Inc. was incorporated in 2012 and is based in Irvine, California.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site